Medicare Enrolled

Dr. Neha Reshamwala, M.D.

Allergy & Immunology · Austin, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
2217 PARK BEND DR, Austin, TX 78758
5123821933
Registered in NPPES since 2007
NPI: 1780874578 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Reshamwala from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reshamwala? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Reshamwala

Dr. Neha Reshamwala is an allergy & immunology specialist in Austin, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Reshamwala performed 3,704 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Reshamwala received a total of $279,673 from 60 pharmaceutical and/or device companies across 995 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Reshamwala is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ Top 37% volume in TX $279,673 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
3,704
Medicare services
Top 37% in TX for allergy & immunology
Not available
Unique patients (not deduplicated)
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Allergy immunotherapy preparation
A professional service involving the preparation and administration of one or more antigens.
2,060 $12 $20
Allergy skin test
A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens.
957 $3 $8
Allergy injection therapy, multiple injections
A professional service involving the administration of multiple allergen injections.
412 $9 $22
Airflow rate measurement test
A test that measures the rate of airflow. This procedure assesses how quickly air moves.
94 $29 $55
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
94 $92 $160
Health risk assessment administration and interpretation
This procedure involves administering a health risk assessment to a patient and interpreting the results.
55 $2 $10
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
19 $108 $240
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
13 $63 $118
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$279,673
Total received (2018-2024)
Avg $39,953/year across 7 years
Top 2% in TX for allergy & immunology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
995
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$47,850
2023
$48,690
2022
$33,399
2021
$43,198
2020
$37,527
2019
$52,917
2018
$16,092

Payments by company (2024)

AstraZeneca Pharmaceuticals LP
$41,412
Novartis Pharmaceuticals Corporation
$3,487
GENZYME CORPORATION
$1,669
Takeda Pharmaceuticals U.S.A., Inc.
$285
Amgen Inc.
$137
CSL Behring
$133
Jubilant HollisterStier LLC
$100
Pharming Healthcare, Inc.
$83
PFIZER INC.
$62
Optinose US, Inc.
$53
kaleo, Inc.
$50
Hikma Pharmaceuticals USA
$50
BioCryst US Sales Co., LLC
$45
Octapharma USA, Inc.
$41
ABBVIE INC.
$37
Greer Laboratories, Inc.
$37
HOSPIRA, INC.
$35
Regeneron Healthcare Solutions, Inc.
$28
Lilly USA, LLC
$28
Phathom Pharmaceuticals, Inc.
$23
Grifols USA, LLC
$20
Circassia Inc.
$20
GlaxoSmithKline, LLC.
$16
Top 3 companies account for 97.3% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$235,001
Shire North American Group Inc
$18,181
Amgen Inc.
$8,288
Takeda Pharmaceuticals U.S.A., Inc.
$4,064
Novartis Pharmaceuticals Corporation
$3,878
GENZYME CORPORATION
$1,993
GlaxoSmithKline, LLC.
$1,360
Regeneron Healthcare Solutions, Inc.
$529
CSL Behring
$506
BioCryst US Sales Co., LLC
$456
Genentech USA, Inc.
$422
Octapharma USA, Inc.
$388
kaleo, Inc.
$323
Pharming Healthcare, Inc.
$295
Otsuka America Pharmaceutical, Inc.
$289
Alkermes, Inc.
$285
Genentech, Inc.
$263
ABBVIE INC.
$247
ALK-Abello, Inc
$224
OptiNose US, Inc.
$206
Aimmune Therapeutics, Inc.
$175
Teva Pharmaceuticals USA, Inc.
$163
Grifols USA, LLC
$153
Lundbeck LLC
$139
PFIZER INC.
$138
Neurocrine Biosciences, Inc.
$124
ITI, Inc.
$102
Jubilant HollisterStier LLC
$100
Janssen Pharmaceuticals, Inc
$97
Sunovion Pharmaceuticals Inc.
$95
Optinose US, Inc.
$94
Neos Therapeutics, LP
$92
AbbVie Inc.
$91
Ironshore Pharmaceuticals Inc.
$89
Mylan Specialty L.P.
$67
Greer Laboratories, Inc.
$67
Hikma Pharmaceuticals USA
$64
Boehringer Ingelheim Pharmaceuticals, Inc.
$55
Kaleo, Inc.
$53
Corium, LLC
$52
Mylan Pharmaceuticals Inc.
$42
Blueprint Medicines Corporation
$36
HOSPIRA, INC.
$35
Arbor Pharmaceuticals, Inc.
$30
Adlon Therapeutics L.P.
$29
ARBOR PHARMACEUTICALS, INC.
$29
JAZZ PHARMACEUTICALS INC.
$28
Lilly USA, LLC
$28
Tris Pharma Inc
$26
Phathom Pharmaceuticals, Inc.
$23
Axsome Therapeutics, Inc.
$21
BioCryst Pharmaceuticals, Inc.
$20
Circassia Inc.
$20
Phadia US Inc.
$16
Bausch Health US, LLC
$16
Avanir Pharmaceuticals, Inc.
$14
Vanda Pharmaceuticals Inc.
$14
AIMMUNE THERAPEUTICS, INC.
$13
Merck Sharp & Dohme Corporation
$11
Circassia Pharmaceuticals Inc
$11
Top 3 companies account for 93.5% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ADHANSIA XR · AIRSUPRA · ARISTADA · ASMANEX · AUSTEDO · AUVI-Q · AYVAKIT · AZSTARYS · Adzenys XR-ODT · Auvelity · Auvi-Q · Azstarys · BREO · BREZTRI · BRINTELLIX · CAPLYTA · CINQAIR · CINRYZE · COTEMPLA XR-ODT · CUTAQUIG · CUVITRU · DERMATITIS - DISEASE · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dyanavel XR · Dymista · EBGLYSS · EOHILIA · FASENRA · Gamunex-C · Grastek · HETLIOZ · HYQVIA · Haegarda · Hizentra · Horizant · INGREZZA · ImmunoCAP · JORNAY PM · LONHALA MAGNAIR · NIOX · NUCALA · NUEDEXTA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ORALAIR · ORLADEYO · Odactra · Orladeyo · PALFORZIA · PANZYGA · PAZEO · Palforzia · REXULTI · RUCONEST · Ragwitek · Ryaltris · SPIRIVA · SPIRIVA RESPIMAT · SPRAVATO · STANDARDIZED · SUNOSI · SYMBICORT · TAKHZYRO · TEZSPIRE · TIMOTHY · TRELEGY ELLIPTA · TRINTELLIX · TUDORZA PRESSAIR · Utibron · VOQUEZNA · VRAYLAR · VYVANSE · WELLBUTRIN · XOLAIR · Xembify · Xhance · Xolair · Yupelri
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an allergy & immunology specialist in Austin?
Compare allergy & immunologists in the Austin area by procedure volume, costs, and industry payment transparency.
Browse allergy & immunologists nearby

Geographic Context

Allergy & immunologists in nearby ZIP areas
40
County median income
$97,169
Nearest hospital to ZIP centroid (approximate)
NORTH AUSTIN MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Reshamwala is a mixed practice specialist, with moderate Medicare volume, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Reshamwala experienced with allergy immunotherapy preparation?
Based on Medicare claims data, Dr. Reshamwala performed 2,060 allergy immunotherapy preparation services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Reshamwala receive payments from pharmaceutical companies?
Yes. Dr. Reshamwala received a total of $279,673 from 60 companies across 995 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reshamwala's costs compare to other allergy & immunologists in Austin?
Dr. Reshamwala's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reshamwala) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →